Abstract
Since COVID-19 was declared a pandemic in March 2020, there has been extensive human-to-human transmission, resulting in substantial respiratory pathology and manifestations outside the pulmonary parenchyma[1,2]. Initial observations showed that the hyper-inflammatory response induced by COVID-19 often led to systemic coagulation derangement and coagulopathy, with thrombosis an important factor in the pathology and clinical course of infection[3–5]. […]
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
